LINC02705

Across TCGA pan-cancer cohorts, LINC02705 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02705’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02705 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02705 is over-expressed in tumor, although a few such as BRCA and LIHC show the opposite, repressed pattern.

KIRC, BRCA, and LIHC are the cancer types where LINC02705 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02705 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.339	<.001	11	view →
BRCA	All	III,IV	−0.396	<.001	6	view →
LIHC	All	All	−0.117	<.001	5	view →
LUSC	All	All	−0.161	.006	4	view →
COAD	All	All	−0.109	.023	2	view →
HNSC	Female	IV	+0.108	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02705–KIRC

Open the KIRC breakdown →